Phase I NSCLC trials shrink and cluster in major U.S. cities
Summary
Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decre...
Description
Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decre...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source